Podcasts about therapies

Send us a textIn this episode of The Incubator Podcast, Ben and Daphna sit down with certified birth doula and lactation counselor Latoya Southwell for a wide-ranging conversation about the role doulas play in supporting families before, during, and after birth. LaToya shares her personal and professional path into birth work, and how her experiences shaped a culturally sensitive, trauma-informed approach to supporting laboring people—particularly those from historically marginalized communities.The conversation covers what doulas do (and don't do), how they differ from midwives, and how they advocate for safe, informed, and emotionally grounded birth experiences. LaToya talks candidly about how she prepares clients for unexpected outcomes, including C-sections and NICU admissions, and how doulas can collaborate with healthcare teams rather than be in conflict with them.She also introduces the Baby Café initiative—an informal peer support network she co-founded to reduce isolation and provide postpartum support for new mothers—and explains why preparing families for postpartum is just as critical as planning for labor.This episode is a practical introduction to the real work of birth doulas—and an invitation to rethink how care teams can work together to improve outcomes and experiences for parents and babies alike. Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Joe DePinto, MBA, Head of Cell, Gene & Advanced Therapies at McKesson, joins the show to discuss InspiroGene, McKesson's end-to-end platform built to address the complex delivery, coordination, and commercialization needs of cell and gene therapies. He breaks down how InspiroGene integrates logistics, specialty pharmacy, patient support services, and real-time data tracking to close critical gaps in the CGT ecosystem—especially around why many eligible patients are still not being identified, referred, or treated. He also explores the broader vision: enabling scalable access to these therapies as they move from rare diseases to larger populations, and what it will take—from providers, payers, and pharma—to meet that future. Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on YouTube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA

In this episode, host Sara Rubin is joined by Cheryl Allen, RPh, founding partner at Curatio Advisors, to explore how manufacturers can evolve their access strategies in response to the growing complexity of specialty-like therapies. With a career spanning specialty pharmacy, digital health innovation and commercialization strategy, Cheryl shares how reframing these products as “enhanced retail” can unlock smarter, patient-centered support models.The conversation highlights how patient voices are shaping the next generation of hub services, starter kits and adherence programs, and why a product's clinical and administrative profile should inform infrastructure decisions from day one. Cheryl offers actionable guidance on building programs that not only help patients start therapy, but support long-term persistence in a fragmented and demanding access environment.The views expressed in this podcast belong solely to the speakers and do not represent those of their organization. If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you'll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at insightshub.health. Like what you're hearing? Be sure to rate and review us! We want to hear from you! If there's a topic you'd like us to cover on a future episode, contact us at podcast@syneoshealth.com.

How quickly does SAINT work? What is the success rate for SAINT? Who is eligible for SAINT? What is SAINT therapy? What are the side effects or risks of SAINT? Joining us to discuss is Nicholas Trapp, MD, assistant professor of psychiatry at the University of Iowa. American Medical Association CXO Todd Unger hosts.

Adam Brufsky, MD, PhD / Rebecca Dent, MD, FRCP (Canada) - Same Class, Different Agents: Practical Considerations for Managing Toxicities of Interest in Patients on TROP2-Directed Therapies in Breast Cancer

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/ZEV865. CME/MOC/AAPA credit will be available until June 30, 2026.Precision Matters in NSCLC: Everything You Need to Know About Biomarker Testing and Targeted Therapies In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation, ONC Brothers. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AbbVie, AstraZeneca, Johnson & Johnson, Lilly, Nuvalent, Nuvation Bio, and Rigel Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/ZEV865. CME/MOC/AAPA credit will be available until June 30, 2026.Precision Matters in NSCLC: Everything You Need to Know About Biomarker Testing and Targeted Therapies In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation, ONC Brothers. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AbbVie, AstraZeneca, Johnson & Johnson, Lilly, Nuvalent, Nuvation Bio, and Rigel Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

Send us a textIn this episode of From the Heart, Dr. Nim Goldshtrom and Dr. Adrianne Bischoff walk through a complex neonatal case involving sudden decompensation shortly after birth. With few early clues and no clear diagnosis, the team discusses how to approach circulatory shock, differentiate pulmonary hypertension from congenital heart disease, and manage critically ill neonates before imaging is available.Using this case as a reverse journal club, the hosts break down relevant literature and decision-making pathways: when to start prostaglandin, when epinephrine makes sense even without low blood pressure, and why relying only on numbers like MAP can be misleading. They also examine the role of therapeutic hypothermia in unstable infants and the potential cardiovascular consequences of cooling.Later, the conversation focuses on left ventricular dysfunction, balancing systemic and pulmonary circulation via the ductus, and using bedside markers like lactate and perfusion to guide treatment when echo isn't immediately available. The episode closes with thoughts on autoregulation, cerebral protection, and the evolving role of emerging technologies in neonatal hemodynamics.A real-world deep dive into diagnostic uncertainty, evolving physiology, and decision-making under pressure in the NICU. Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Learn what makes Better Belly Therapies different from other gut health programs, and why our program is so successful. --Have you been listening to the Better Belly Podcast for a while and want to work with us, but you aren't sure what offer is best for you?Or - have you been recommended to work with us, and you were recommended to listen to this episode?Or - are you not familiar at all with how we work with people, and you just want to know more about our offers? If so, then today's episode is for you! On today's episode, I'm answering all questions related to the ways we work with people here at Better Belly Therapies. To do this conversation, I actually invited my friend Lynne Furtado onto the episode to have the conversation LIVE and ask real questions to me as I explain the programs. Because - it's more fun to have a conversation like this with a real person asking real questions rather than just monologuing into the mic! Today, we'll be covering questions like: How is our program different than others? Why would someone want to go to our program as opposed to somebody else's? What makes us more successful than other programs?Can we handle sensitive patients?How exactly do our offers work / what is the experience you'll have inside them? If you're an audio learner or you don't want to take time to read through our website to learn about how we work with people, then I hope today's episode clears up some questions for you and helps you feel more confident in taking your next steps forward to heal. TIMESTAMPS:00:00 - Introduction to Better Belly Therapies 02:25 - Meet Lynn Ferdo and the Episode's Purpose 05:17 - Allison's Personal Health Journey 10:11 - The Better Belly Blueprint Explained 12:17 - Client Success Stories and Testimonials 22:16 - Lab Testing and Customization 25:45 - Cost Awareness and Program Flexibility 30:23 - Exclusive Coaching Offer 30:39 - Benefits of Daily Coaching 31:47 - Affordable Yearly Subscription 32:14 - Live Group Coaching Calls 33:03 - Personal Experiences with Mold 35:51 - Healing Journey and Discoveries 41:11 - VIP Program Details 48:13 - Pediatric VIP Program 52:25 - Free vs. Paid Facebook Groups 54:22 - Final Thoughts and Encouragement EPISODES MENTIONED:245// The Best Air Filter for Mold: HEPA Filters vs. Hi-Tech Air Reactor 246// How This Air Filter STOPPED Her Toxic Mold Symptoms from Escalating245// The Best Air Filter for Mold: HEPA Filters vs. Hi-Tech Air Reactor HEAL YOUR GUT TODAY!Option #1)

In this episode of MedNews Week's Oncology Unplugged, host Chandler Park, MD, a medical oncologist at Norton Cancer Institute in Louisville, Kentucky, was rejoined by Midhun Malla, MD, of the University of Alabama at Birmingham, to discuss therapeutic options for patients with metastatic colorectal cancer (mCRC), particularly in the third-line setting and beyond. In the final part of this 3-part episode miniseries, Drs Park and Malla explored the challenges faced by community oncologists, especially in rural or underserved areas, in accessing clinical trials, which remain a preferred disease management approach due to their role in advancing novel therapies. However, in the absence of trial availability or when patients are ineligible, they emphasized the importance of evidence-based, FDA-approved agents for later lines of therapy. Three primary agents were discussed for patients who have progressed on first-line FOLFOX (folinic acid, fluorouracil, and oxaliplatin) and second-line FOLFIRI (folinic acid, fluorouracil, and irinotecan) regimens: trifluridine/tipiracil (TAS-102; Lonsurf) plus bevacizumab (Avastin); fruquintinib (Fruzaqla); and regorafenib (Stivarga). These agents offer viable treatment pathways in biomarker-unselected patient populations. However, direct comparisons between these agents are lacking, as most were tested against placebo controls. The choice among them is often individualized based on patient performance status, prior exposure to biologics, and toxicity profiles. TAS-102 plus bevacizumab has generated promising results, though real-world data may show diminished efficacy due to frequent prior exposure to 5-fluorouracil and bevacizumab in US patients. Fruquintinib offers a VEGF-targeted approach with a more favorable hematologic toxicity profile, whereas regorafenib is associated with notable adverse effects, including hypertension, gastrointestinal toxicity, and mucositis. Park and Malla emphasized the importance of treatment sequencing, toxicity management, and individualized patient-centered care, including consideration of dose modifications to preserve quality of life in later-line settings. In addition to later-line options, the conversation also touched on emerging frontline therapies. Notable investigational agents include zanidatimab-hrii (Ziihera) and KRAS G12C–directed therapies. Additionally, a novel integrin-targeted cytotoxin is currently under evaluation at the University of Alabama at Birmingham in patients with treatment-naive mCRC. This agent induces apoptosis via caspase-8 activation and has demonstrated encouraging preclinical activity. Overall, the discussion highlighted a nuanced, biomarker-informed, and patient-tailored approach to mCRC management, emphasizing both the value of clinical trials and the importance of optimizing currently available therapies.

With BCG in short supply and recurrence rates still high, the race is on for better intravesical options. In this episode of BackTable Tumor Board, Dr. Lindsey Herrel, urologic oncologist at the University of Michigan, joins Dr. Ruchika Talwar to explore the evolving landscape of intravesical therapy for intermediate risk bladder cancer. --- This podcast is supported by an educational grant from UroGen Pharma. --- SYNPOSIS The doctors break down the nuances of defining this risk category and the clinical gray zones that complicate treatment decisions. Dr. Herrell shares her patient-centered approach to surveillance and therapy, and introduces promising new agents, including Anktiva, UGN-102, and the gemcitabine-releasing TAR-200 "pretzel" device. The discussion also highlights how advances in molecular profiling are reshaping care strategies.This episode underscores the urgent need for clearer guidelines and continued innovation to improve outcomes and quality of life for patients with this nuanced disease subtype. --- TIMESTAMPS 00:00 - Introduction02:03 - Defining Intermediate Risk Bladder Cancer06:12 - Intravesical Therapy Options08:47 - Quality of Life and Patient Counseling10:18 - New Treatments on the Horizon12:56 - Practical Tips for TURBT Recovery17:03 - In-Office Procedure Management21:38 - Managing Symptoms and Quality of Life31:50 - A Note on Smoking Cessation33:37 - Conclusion and Future Directions

In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Arsalan Arif, founder of Endpoints News, for a wide-ranging conversation on the business of biotech. From his early days bootstrapping a media company to Endpoints' recent partnership with the Financial Times, Arsalan shares his journey and reflections on what it takes to build trust in an evolving industry.Together, they unpack today's cell and gene therapy landscape, where clinical success alone isn't enough. Arsalan offers his perspective on investor sentiment, why scaling remains the biggest challenge in CGT, and how economic models, not efficacy, will shape the next chapter of growth.Learn more about Arsalan: https://www.linkedin.com/in/arsalanarif/

Sign up to Easy Ayurveda Video Classes by clicking the link belowhttps://www.easyayurveda.com/video-classes/Video Course: “Ayurvedic food and Nutrition”https://www.easyayurveda.com/nutrition/Buy Tridosha Made Easy Bookhttps://www.easyayurveda.com/tridosha-made-easy-3/Buy Tridosha Made Easy Book in Spanish LanguageEl corazón de los doshas: Nuevo librohttps://www.easyayurveda.com/el-corazon-de-los-doshas/Click to know more about Easy Ayurveda Hospitalhttps://www.easyayurveda.com/hospital/Buy our new course on Marma Therapy Part 1https://www.easyayurveda.com/marma1Buy our new course on Marma Therapy Part 1Subscribe to Easy Ayurveda Video Classes https://www.easyayurveda.com/video-classes/Subscribe to our free Easy Ayurveda newsletter here (you can unsubscribe and stop them anytime) -  https://forms.aweber.com/form/58/2129766958.htm Buy our course on diabetes reversal, powered by Madhavbaug https://www.easyayurveda.com/diabetes Buy our online video course on Treatment of cardiac disorders with Ayurveda https://www.easyayurveda.com/heartMaster ECG in one week. Sign up for video course https://www.easyayurveda.com/ecgContact Dr. MB Gururaja BAMS MD (Ayu)https://www.easyayurveda.com/gururaja  Contact Dr. Raghuram YS BAMS MD (Ayu)https://www.easyayurveda.com/raghuram Buy Easy Ayurveda Ebooks https://www.easyayurveda.com/my-book Buy Easy Ayurveda Printed Books https://www.easyayurveda.com/books/

Sign up to Easy Ayurveda Video Classes by clicking the link belowhttps://www.easyayurveda.com/video-classes/Video Course: “Ayurvedic food and Nutrition”https://www.easyayurveda.com/nutrition/Buy Tridosha Made Easy Bookhttps://www.easyayurveda.com/tridosha-made-easy-3/Buy Tridosha Made Easy Book in Spanish LanguageEl corazón de los doshas: Nuevo librohttps://www.easyayurveda.com/el-corazon-de-los-doshas/Click to know more about Easy Ayurveda Hospitalhttps://www.easyayurveda.com/hospital/Buy our new course on Marma Therapy Part 1https://www.easyayurveda.com/marma1Buy our new course on Marma Therapy Part 1Subscribe to Easy Ayurveda Video Classes https://www.easyayurveda.com/video-classes/Subscribe to our free Easy Ayurveda newsletter here (you can unsubscribe and stop them anytime) -  https://forms.aweber.com/form/58/2129766958.htm Buy our course on diabetes reversal, powered by Madhavbaug https://www.easyayurveda.com/diabetes Buy our online video course on Treatment of cardiac disorders with Ayurveda https://www.easyayurveda.com/heartMaster ECG in one week. Sign up for video course https://www.easyayurveda.com/ecgContact Dr. MB Gururaja BAMS MD (Ayu)https://www.easyayurveda.com/gururaja  Contact Dr. Raghuram YS BAMS MD (Ayu)https://www.easyayurveda.com/raghuram Buy Easy Ayurveda Ebooks https://www.easyayurveda.com/my-book Buy Easy Ayurveda Printed Books https://www.easyayurveda.com/books/

Jo Cheah chats to dermatologist Jonathan Chan about the latest therapies for psoriasis. Jonathan outlines the different treatments for mild to moderate and moderate to severe psoriasis, and when to refer patients to a non-GP specialist. They discuss the benefits and risks associated with biologic medicines for psoriasis, and considerations for patients with comorbidities. Read the full article by Jonathan in Australian Prescriber.

In this episode of THE MENTORS RADIO, Host Dan Hesse talks with Dr. Paul Christo, author and award-winning physician renown for his cutting-edge work as a pain specialist. Pain, if left untreated, can impact our performance and productivity, and even our enjoyment of life. In this episode, Dr. Christo discusses breakthrough techniques and therapies that can relieve even the most severe chronic pain. One of the world's leading pain specialists, Dr. Christo is the author of Aches and Gains, A Comprehensive Guide to Overcoming Your Pain. He is the Chief of the Division of Pain Medicine at the Johns Hopkins University School of Medicine. Paul is also a frequent contributor on NBC, CBS, ABC, FOX, and PBS television regarding pain and addiction. He hosts an award-winning, nationally syndicated SIRIUS XM radio talk show called Aches and Gains®. The show provides hope and treatment options for those suffering from medical illnesses, diseases, and the pain that often results from these conditions. Dr. Christo is an invited lecturer both nationally and internationally, serves on four journal editorial boards, has published more than 100 articles and book chapters, co-edited five textbooks on pain, and actively teaches medical students, residents, and pain fellows. Paul also earned an MBA from the Johns Hopkins Carey Business School in Health Care Management.  This conversation can change how you show up—in every area of life, including business, family and work. Listen to THE MENTORS RADIO broadcast on Salem Radio in San Francisco, via live-streaming on iHeart Radio worldwide or anytime, on ANY podcast platform, including Apple Podcast, Spotify, iTunes, TuneIN, Stitcher, Google Play and all the others. Sign up for the podcast here. SHOW NOTES: DR. PAUL CHRISTO: BIO: BIO: Dr. Paul Christo BOOK: Aches and Gains- A Comprehensive Guide to Overcoming Your Pain, by Dr. Paul Christo, Dale Leopold, et al. WEBSITE: Aches and Gains Radio Show

This week, we present an inspiring episode for anyone interested in the history, present, and future of prostate cancer care. In this Legends in Urology installment of the BackTable Urology Podcast, Dr. Gerald Andriole joins guest host Dr. Niraj Badhiwala to reflect on a career that has left a lasting impact on the field. --- SYNPOSIS Dr. Andriole shares personal stories from his upbringing in Northeastern Pennsylvania and his journey into medicine. He reflects on his expedited education through Penn State and Jefferson Medical College and his path to urology. He discusses his pivotal work in prostate cancer screening, including the influence of major trials like The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, and traces the evolution of surgical and diagnostic techniques. The conversation also touches on current innovations and the future of prostate cancer management, offering valuable advice for the next generation of urologists. --- TIMESTAMPS 00:00 - Introduction01:59 - From Childhood to Medical School06:48 - Discovering Urology16:52 - Pioneering Prostate Cancer Screening24:07 - The PLCO Study: Design and Challenges28:57 - Controversies and Criticisms in Prostate Cancer Screening33:29 - Evolving Practices in Prostate Cancer Management44:19 - Future of Prostate Cancer Treatment

A lot of common joint problems like shoulder pain, carpal tunnel, or plantar fasciitis can actually come from imbalances in how our muscles work, not just wear and tear. When certain muscles are overused or stuck in the same position too long, they start to pull differently, which can throw off how our joints move and feel.It highlights how simple movements and daily habits can help reset that balance. From easy hand exercises to tips for shoulder and back pain, it offers practical ways to feel better and move more freely. There's also helpful advice for spotting early signs of scoliosis in kids, which can make a big difference down the road.Highlights of the Podcast00:04 - Understanding Joint Pain and Muscle Tone01:21 - How Posture and Position Reset Muscle Tone02:27 - Shoulder Pain in Lifters03:45 - Neurologic Reflexive Inhibition Explained04:45 - Carpal Tunnel: Muscle Imbalance from Overuse05:14 - How to Rebalance Hand and Wrist Muscles06:54 - Therapies for Shoulder and Foot Pain08:22 - Imaging for Persistent Pain09:48 - Importance of Hamstring Flexibility11:17 - Functional Training Tips for Lifters12:35 - Preventing Shoulder Injuries in Lifters13:25 - Early Scoliosis Detection in Girls

In today's episode, we had the pleasure of speaking with Alexey Danilov, MD, PhD, about current challenges and emerging treatment approaches for the management of leukemia and lymphoma that were published in a manuscript based on proceedings from the inaugural Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Conference. Dr Danilov is the Marianne and Gerhard Pinkus Professor of Early Clinical Therapeutics, medical director of the Early Phase Therapeutics Program for the Systems Clinical Trials Office, co-director of the Toni Stephenson Lymphoma Center, and a professor in the Division of Lymphoma in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope in Duarte, California. In our exclusive interview, Dr Danilov highlighted recent advances and controversies in the treatment of select patients with hematologic malignancies. He noted chemotherapy-free regimens that are shifting treatment paradigms in mantle cell lymphoma, preferred and emerging BTK inhibitors for the management of chronic lymphocytic leukemia, and the evolution of CD19-directed CAR T-cell therapies for diffuse large B-cell lymphoma. Dr Danilov concluded by taking a forward glance at future developments like BTK degraders and novel CAR T-cell therapy targets.

One of the challenges of delivering gene therapies to the eye is that once a subretinal injection is made, the therapy's distribution is confined to the margins of the pocket of fluid that is created, known as a bleb. Atsena, which is developing gene therapies for X-linked retinoschisis and Leber congenital amaurosis 1, uses its AAV.SPR technology that allows the gene therapy to spread laterally after injection. We spoke to Patrick Ritschel, CEO of Atsena Therapeutics, about the challenges of gene therapies for inherited retinal diseases, how the company's unique vector technology addresses this, and how it allows for safer and more effective delivery of gene therapies to the retina.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZFA865. CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE credit will be available until June 18, 2026.Navigating Advances in Alzheimer's Disease: Practical Strategies for Integrating New Diagnostic Tools and Amyloid-Targeting Therapies Into Patient Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and BrightFocus Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZFA865. CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE credit will be available until June 18, 2026.Navigating Advances in Alzheimer's Disease: Practical Strategies for Integrating New Diagnostic Tools and Amyloid-Targeting Therapies Into Patient Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and BrightFocus Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZFA865. CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE credit will be available until June 18, 2026.Navigating Advances in Alzheimer's Disease: Practical Strategies for Integrating New Diagnostic Tools and Amyloid-Targeting Therapies Into Patient Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and BrightFocus Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZFA865. CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE credit will be available until June 18, 2026.Navigating Advances in Alzheimer's Disease: Practical Strategies for Integrating New Diagnostic Tools and Amyloid-Targeting Therapies Into Patient Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and BrightFocus Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZFA865. CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE credit will be available until June 18, 2026.Navigating Advances in Alzheimer's Disease: Practical Strategies for Integrating New Diagnostic Tools and Amyloid-Targeting Therapies Into Patient Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and BrightFocus Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZFA865. CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE credit will be available until June 18, 2026.Navigating Advances in Alzheimer's Disease: Practical Strategies for Integrating New Diagnostic Tools and Amyloid-Targeting Therapies Into Patient Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and BrightFocus Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZFA865. CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE credit will be available until June 18, 2026.Navigating Advances in Alzheimer's Disease: Practical Strategies for Integrating New Diagnostic Tools and Amyloid-Targeting Therapies Into Patient Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and BrightFocus Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZFA865. CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE credit will be available until June 18, 2026.Navigating Advances in Alzheimer's Disease: Practical Strategies for Integrating New Diagnostic Tools and Amyloid-Targeting Therapies Into Patient Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and BrightFocus Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

Dr Erin Louise Bellamy founded Integrative Ketogenic Research and Therapies which uses principles of Metabolic Psychiatry to provide remote, highly personalized 1:1 Metabolic Therapy for both psychiatric conditions and overall metabolic health. Dr. Erin Bellamy has a PhD in Psychology, specializing in Ketogenic Diets & Depression from the University of East London. She also has an MSc in Psychiatric Research from the Institute of Psychiatry at King's College London. She is a Chartered Psychologist, an Associate Fellow of the British Psychological Society and an accredited member of the Society of Metabolic Health Practitioners. In this episode, Drs. Brian and Erin talk about… (00:00) Intro (01:36) How Dr. Erin became interested in Metabolic Psychiatry (05:38) Ketogenic diets and psychiatric conditions (15:39) Fasting and mental clarity (18:12) The areas in which clinical psychology is deficient in helping patients (23:46) Adverse childhood events, PTSD, and metabolic health (28:24) Binge eating, stress, and support groups (40:00) Food addiction and ketosis (43:59) Schizophrenia, autism, and ketosis (01:00:46) Outro/plugs For more information, please see the links below. Thank you for listening! Links: Please consider supporting us on Patreon: https://www.lowcarbmd.com/ Resources Mentioned in this Episode: Dr. Erin Bellamy on the Life's Best Medicine Podcast: https://lifesbestmedicine.com/podcast/episode-248-dr-erin-bellamy/ Dr. Erin Bellamy: Instagram: https://www.instagram.com/erinlouisebellamy/ X: https://x.com/erinlbellamy Integrative Ketogenic Research & Therapies: https://www.ikrt.org Dr. Brian Lenzkes:  Website: https://arizonametabolichealth.com/ Twitter: https://twitter.com/BrianLenzkes?ref_src=twsrc^google|twcamp^serp|twgr^author Dr. Tro Kalayjian:  Website: https://www.doctortro.com/ Twitter: https://twitter.com/DoctorTro Instagram: https://www.instagram.com/doctortro/ Toward Health App Join a growing community of individuals who are improving their metabolic health; together.  Get started at your own pace with a self-guided curriculum developed by Dr. Tro and his care team, community chat, weekly meetings, courses, challenges, message boards and more.  Apple: https://apps.apple.com/us/app/doctor-tro/id1588693888  Google: https://play.google.com/store/apps/details?id=uk.co.disciplemedia.doctortro&hl=en_US&gl=US Learn more: https://doctortro.com/community/ 

Gene therapies have been in the news lately. They are being used to help individuals who have a genetic variant linked to a disorder or disease, including but not limited to: spinal muscular atrophy, carbamoyl phosphate synthetase 1 (CPS1) deficiency, diabetes and some types of cancers. What is the promise in rare genetic forms of … Continue reading "Genetic therapies in store for neurodevelopmental disorders"

This week, Russell, Mike, and Clarissa discuss the continuing immigration protests in Los Angeles and the complexities of food aid to Gaza. Regina Chow Trammel, therapist and professor of social work at Azusa Pacific University, and CT's Israel correspondent, Jill Nelson, join the conversation.   GO DEEPER WITH THE BULLETIN:  Join the conversation at our Substack Find us on YouTube.  Rate and review the show in your podcast app of choice.  ABOUT THE GUESTS:   Regina Chow Trammel, PhD, LCSW, is professor of the master of social work program at Azusa Pacific University. She has spent more than a decade in private practice and has years of experience in psychiatric and medical social work settings. She has academic research publications on Christian mindfulness and a TEDx talk on mindfulness and cowrote A Counselor's Guide to Christian Mindfulness: Engaging the Mind, Body & Soul in Biblical Practices & Therapies. Jill Nelson is Christianity Today's Ukraine and Israel correspondent. She holds a master's in Middle Eastern studies from the University of Texas and began her journalism career as a reporter and anchor in South Dakota. For nearly 20 years, she covered Ukraine and the Middle East for World News Group.    ABOUT THE BULLETIN:  The Bulletin is a twice-weekly politics and current events show from Christianity Today moderated by Clarissa Moll, with senior commentary from Russell Moore (Christianity Today's editor in chief) and Mike Cosper (director, CT Media). Each week, the show explores current events and breaking news and shares a Christian perspective on issues that are shaping our world. We also offer special one-on-one conversations with writers, artists, and thought leaders whose impact on the world brings important significance to a Christian worldview, like Bono, Sharon McMahon, Harrison Scott Key, Frank Bruni, and more.    The Bulletin listeners get 25% off CT. Go to https://orderct.com/THEBULLETIN to learn more.    “The Bulletin” is a production of Christianity Today Producer: Clarissa Moll Associate Producer: Alexa Burke Editing and Mix: TJ Hester Music: Dan Phelps Executive Producers: Erik Petrik and Mike Cosper   Senior Producer: Matt Stevens Learn more about your ad choices. Visit podcastchoices.com/adchoices

Can we do more than prescribe pills to address men's sexual health complaints? In this episode of the BackTable Urology Podcast, men's health expert Dr. Mohit Khera from Baylor College of Medicine joins guest host Dr. Amy Pearlman for a deep dive into testosterone management and the full spectrum of erectile dysfunction therapies. --- SYNPOSIS The conversation covers daily tadalafil use, lifestyle optimization, and the nuanced role of off-label medications. Dr. Khera also highlights emerging technologies like the Tech Ring and radiofrequency treatments, alongside practical insights into semen analysis and hormonal health markers. Throughout, he emphasizes a holistic, patient-centered approach to sexual health—blending medical therapy with meaningful lifestyle change. This is a must-listen for general urologists, men's health specialists, and trainees looking to expand their toolkit in this evolving field. --- TIMESTAMPS 00:00 - Introduction02:13 - Erectile Dysfunction and Testosterone08:05 - Young Men's Health and Early Detection10:20 - Semen Analysis for Overall Health12:50 - Daily Tadalafil and Its Benefits16:40 - Proactive Sexual Health Management21:28 - Female Sexual Health25:16 - Treating Delayed Ejaculation28:53 - Psychogenic Erectile Dysfunction31:16 - Technology in Sexual Health35:54 - Lifestyle Modifications for Better Sexual Health41:55 - Resources and Referrals for Patients44:30 - Final Thoughts

Annaka Harris is the New York Times–bestselling author of Conscious: A Brief Guide to the Fundamental Mystery of the Mind and the upcoming audio documentary Lights On: How Understanding Consciousness Helps Us Understand the Universe which wasl exclusively released on March 18, 2025 at audiobook retailers like Spotify, Audible, Apple Books, and the Libby App. Harris is an editor and consultant for science writers, specializing in neuroscience and physics, and her work has appeared in The New York Times. Annaka is the author of the children's book I Wonder, a collaborator on the Mindful Games Activity Cards by Susan Kaiser Greenland, and a volunteer mindfulness teacher for the Inner Kids organization.

In a medical first, a team at Children's Hospital of Philadelphia and Penn Medicine has successfully treated an infant diagnosed with a rare genetic disorder by using a customized CRISPR gene editing therapy. The work, led by Penn Medicine's Kiran Musunuru and CHOP's Rebecca Ahrens-Nicklas, points to the potential to use bespoke gene editing therapies to treat others with rare genetic diseases for which no available medicines exist. We spoke to P.J. Brooks, deputy director of the Office of Rare Disease Research at the National Institutes of Health's National Center for Advancing Translational Sciences, about the breakthrough treatment, how the researchers were able to move from diagnosis to treatment with great speed, and what it would take to scale such an approach.

Send us a textDenise Potter is a returning guest on our show! Be sure to check out her appearance on episode 573 of Boundless Body Radio!Denise Potter, RD has been a Registered Dietitian Nutritionist for 30 years. For the past 15 years she has focused on Ketogenic Medical Nutrition Therapy. She strives to provide client-centered, personalized therapy, counseling, and education.Denise has a passion for helping under-served populations benefit from Ketogenic Diet Therapies. Throughout her career, Denise has worked with clients of all ages, guiding them through a diverse range of medical conditions, including epilepsy, cancer, Parkinson's, diabetes, autism, bipolar disorder, and many more.Her extensive knowledge and experience in ketogenic therapies have earned her recognition as a leading expert, and she has had the honor of training healthcare professionals all around the world.Denise is the author of the fantastic book The Migraine Diet: A Ketogenic Meal Plan for Headache Relief.On a personal level, Denise has been married to the love of her life, Terry, for 30 years, has 4 amazing children and loves to laugh, and a big bowl of guac is her love language!Find Denise at-https://www.aktketocommunity.com/https://www.ketomastery.pro/TW- @KetoPotterRDNIG- @ketopotterrdnFind Boundless Body at- myboundlessbody.com Book a session with us here!

On this episode of the Integrative Cancer Solutions podcast Dr. Karlfeldt interviews Dr. Francisco Contreras. Dr. Contreras shares his background, explaining that his father founded their clinic in 1963, introducing a holistic approach to cancer treatment that addresses emotional and spiritual needs alongside physical ones. He recounts significant success stories, including a patient with advanced breast cancer who improved dramatically using alternative therapies. Dr. Contreras received training in Vienna and follows his father's intuitive approach of combining conventional and non-conventional methods. The discussion highlights the complexity of cancer as a disease and the importance of addressing the immune system for long-term treatment success. Dr. Contreras explains various therapies used at the Oasis of Hope, including dendritic cell vaccines, natural killer cells, and tumor infiltrating lymphocytes. He emphasizes the non-toxic nature of cell therapies and their cost-effectiveness in Mexico compared to the United States. The conversation also covers the combination of conventional and alternative treatments, such as low-dose chemotherapy to make tumors more visible to the immune system, along with additional therapies like high-dose vitamin C, vitamin B17, and hyperthermia. Dr. Contreras concludes by explaining the patient consultation process and offering his book "The Art and Science of Undermining Cancer" as a resource for listeners.Dr. Francisco Contreras discusses his family's pioneering work in integrative cancer treatment at Oasis of Hope, founded by his father in 1963, combining conventional medicine with holistic approaches.The podcast emphasizes treating cancer as a metabolic disease rather than just targeting genetic mutations, with special focus on strengthening the immune system for long-term success.Dendritic cell therapy and other cell-based treatments are highlighted as effective, non-toxic approaches that can be more affordable in Mexico than similar treatments in the United States.Dr. Contreras explains how low-dose metronomic chemotherapy can be strategically combined with immune therapies to make tumors more visible to the immune system while reducing regulatory T cells.Additional therapies discussed include high-dose vitamin C, vitamin B17, and hyperthermia, which have contributed to improved five-year survival rates for stage four cancer patients at their clinic.----Grab my book A Better Way to Treat Cancer: A Comprehensive Guide to Understanding, Preventing and Most Effectively Treating Our Biggest Health Threat - https://www.amazon.com/dp/B0CM1KKD9X?ref_=pe_3052080_397514860 Unleashing 10X Power: A Revolutionary Approach to Conquering Cancerhttps://store.thekarlfeldtcenter.com/products/unleashing-10x-power-Price: $24.99-100% Off Discount Code: CANCERPODCAST1Healing Within: Unraveling the Emotional Roots of Cancerhttps://store.thekarlfeldtcenter.com/products/healing-within-Price: $24.99-100% Off Discount Code: CANCERPODCAST2----Integrative Cancer Solutions was created to instill hope and empowerment. Other people have been where you are right now and have already done the research for you. Listen to their stories and journeys and apply what they learned to achieve similar outcomes as they have, cancer remission and an even more fullness of life than before the diagnosis. Guests will discuss what therapies, supplements, and practitioners they relied on to beat cancer. Once diagnosed, time is of the essence. This podcast will dramatically reduce your learning curve as you search for your own solution to cancer. To learn more about the cutting-edge integrative cancer therapies Dr. Karlfeldt offer at his center, please visit www.TheKarlfeldtCenter.com

In this Healthed lecture, Professor Henry Brodaty explains the evidence for the effectiveness of Donanemab in slowing cognitive and functional decline, with the greatest benefit being seen in early-stage patients. In addition, he will discuss the practical aspects of the treatment including patient selection, assessment, referral process as well as how the monthly IV infusions are delivered, monitored, and potential side effects. Professor Brodaty will also address the reality that the effectiveness of donanemab is not universal and careful patient selection and managing expectations is important.See omnystudio.com/listener for privacy information.

Hey, Heal Squad! What if the key to healing wasn't talking about it? In this powerful compilation episode, Maria's walking us through the most eye-opening moments from some of our favorite conversations on non-talk therapies—modalities that help you heal without having to relive the trauma. You'll hear from top experts on everything from JournalSpeak and EMDR, to reflexology and even psychedelics, as they share how these tools work through the nervous system, not just the mind. Whether you've felt stuck in traditional therapy or just curious about other ways to support your healing, this episode will open your eyes to the power of going beyond words. These are the methods helping people release decades of pain, rewire their patterns, and feel safe again—without saying a thing. HEAL SQUAD SOCIALS IG: https://www.instagram.com/healsquad/ TikTok: https://www.tiktok.com/@healsquadxmaria HEAL SQUAD RESOURCES: Heal Squad x Patreon: https://www.patreon.com/HealSquad/membership Maria Menounos Website: https://www.mariamenounos.com My Curated Macy's Page: Shop My Macy's Storefront Prenuvo: Prenuvo.com/MARIA for $300 off Delete Me: https://bit.ly/43rkHwi Code: SQUAD EMR-Tek Red Light: https://emr-tek.com/discount/Maria30 for 30% off Airbnb: https://www.airbnb.com/  Join the In-Person Heal Retreat: https://www.canyonranch.com/stay/events/heal-retreat-with-maria-menounos/?location=lenox  EPISODE RESOURCES: Nicole Sach's Full Episode: https://podcasts.apple.com/us/podcast/1069-repressed-emotions-are-making-you-sick-heal-fatigue/id1320060107?i=1000705382553  Tammy Valicenti's Full Episode: https://podcasts.apple.com/us/podcast/34-healing-trauma-ptsd-with-emdr/id1320060107?i=1000459791683  Gaby Piccirilli's Full Episode: https://podcasts.apple.com/us/podcast/1062-reverse-chronic-pain-naturally-how-to-rewire-your/id1320060107?i=1000703717566  Bob Parson's Full Episode: https://podcasts.apple.com/us/podcast/528-from-broke-to-billionaire-how-vietnam-vet-entrepreneur/id1320060107?i=1000579433973  ABOUT MARIA MENOUNOS: Emmy Award-winning journalist, TV personality, actress, 2x NYT best-selling author, former pro-wrestler and brain tumor survivor, Maria Menounos' passion is to see others heal and to get better in all areas of life. ABOUT HEAL SQUAD x MARIA MENOUNOS: A daily digital talk-show that brings you the world's leading healers, experts, and celebrities to share groundbreaking secrets and tips to getting better in all areas of life. DISCLAIMER: This Podcast and all related content ( published or distributed by or on behalf of Maria Menounos or http://Mariamenounos.com and http://healsquad.com ) is for informational purposes only and may include information that is general in nature and that is not specific to you. Any information or opinions provided by guest experts or hosts featured within website or on Company's Podcast are their own; not those of Maria Menounos or the Company. Accordingly, Maria Menounos and the Company cannot be responsible for any results or consequences or actions you may take based on such information or opinions. This podcast is presented for exploratory purposes only. Published content is not intended to be used for preventing, diagnosing, or treating a specific illness. If you have, or suspect you may have, a health-care emergency, please contact a qualified health care professional for treatment.

Send us a textIn this week's Journal Club, Ben and Daphna dive into the latest report from the American Academy of Pediatrics on the management of patent ductus arteriosus (PDA) in preterm infants. They dissect the nuances of prophylactic versus selective treatment, review recent meta-analyses, and explore why early intervention might not yield better outcomes despite effective PDA closure. They also break down new echocardiographic criteria for diagnosing a hemodynamically significant PDA and discuss the role of transcatheter procedures.The conversation then shifts to MRI timing and classification in neonatal encephalopathy, highlighting recent Canadian consensus recommendations for standardizing imaging protocols post-therapeutic hypothermia. The episode wraps up with a look at the TOHOP trial on permissive hypotension, challenging long-standing blood pressure treatment thresholds in preterm infants.Listeners will gain a pragmatic view of evolving clinical practices and research gaps in neonatal care, particularly for infants with PDA and hypoxic-ischemic encephalopathy. If you're looking to stay current on evidence-based recommendations without the fluff, this episode is for you. As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Drs Sara Horst and Jordan Axelrad Discuss Risks of Malignancy, Infection With IBD Therapies by Gastroenterology Learning Network

253: In this special episode recorded live from the White House, I sit down with some of the most influential voices shaping the future of health in America to discuss the newly released Make America Healthy Again (MAHA) Report. Guests include Dr. Oz, Kyle Diamantas, Vani Hari, Anthony Geisler, Brigham Buhler, and Max Lugavere. We dive into key topics like food policy, GRAS regulations, Medicaid and SNAP reform, PBMs, Alzheimer's research, and the push for preventative care, movement, and accountability in federal health initiatives. This is a behind-the-scenes look at how the MAHA coalition is working to make real change—and what it means for your health. Topics Discussed:  What is the Make America Healthy Again (MAHA) Report, and how does it aim to transform public health policy? How is the FDA planning to update GRAS regulations and food safety standards under the MAHA initiative? What changes are being proposed for Medicaid, Medicare, and SNAP benefits to support preventative health care? Why are PBMs (pharmacy benefit managers) under scrutiny, and how is the MAHA movement addressing prescription drug pricing? What are the latest findings on Alzheimer's disease research, and how is fraudulent science being addressed in national policy? Sponsored By: Beekeepers Naturals | Go to beekeepersnaturals.com/REALFOODOLOGY or enter code REALFOODOLOGY to get 20% off your order.  MASA | Go to MASAChips.com/Realfoodology and use code Realfoodology for 25% off your first order. Ollie | Head to MyOllie.com/REALFOODOLOGY, tell them all about your dog, and use code REALFOODOLOGY to get 60% off your Welcome Kit when you subscribe today!  Timestamps:   00:00:00 - Introduction  00:04:01 - Dr. Oz on CMS & Health Policy 00:06:09 - What MAHA Means for Real Food 00:07:28 - SNAP, Medicaid & Prevention 00:09:33 - Food Access & Health Equity 00:12:21 - Medicaid Waste & ACA Reform 00:15:16 - Movement, Sleep & Food w/ Anthony Geisler 00:17:14 - MAHA's Core 4 Explained 00:18:58 - Building Daily Healthy Habits 00:23:31 - Fitness Access in Schools & Communities 00:26:35 - Avoiding Burnout & Staying Consistent 00:29:33 - Kyle Diamantas on the MAHA Report 00:32:42 - GRAS Status & FDA Priorities 00:36:15 - FDA Reform & Food Regulation 00:39:26 - Red Dye, Food Bans & Ingredient Risks 00:42:14 - Vani Hari on MAHA & Food Advocacy 00:47:54 - Government Response to Health Demands 00:50:52 - MAHA Criticism & What's Ahead 00:56:06 - Fixing How We Grow & Source Food 00:59:59 - Whole Foods, Prevention & EO Impact 01:01:22 - Alzheimer's Fraud & Science Gaps 01:05:29 - New Alzheimer's Therapies & Creatine 01:10:38 - Brigham Buhler on FDA & Reform Efforts 01:12:05 - FDA Accountability & Future Goals 01:14:13 - GRAS Loopholes & Public Safety 01:15:55 - Strengthening Health Safety Nets 01:18:43 - Medical Overuse & Systemic Issues 01:20:30 - What Are PBMs & Why They Matter 01:23:10 - U.S. vs. Global Drug Pricing 01:24:18 - Trump's EO & Cutting Out PBMs 01:26:33 - Insurance Denials & Patient Delays 01:29:10 - Insurance Fixes from the Ground Up 01:32:21 - Progress in Reforming Health Insurance Show Links: Former Pharma Rep Breaks Down How Your Insurance Is Overcharging You + Keeping You Sick | Brigham Buhler Check Out:  Dr. Oz Anthony Geisler, CEO of Sequel Brands Kyle Diamantas Vani Hari Max Lugavere Brigham Buhler Check Out Courtney:  LEAVE US A VOICE MESSAGE Check Out My new FREE Grocery Guide! @realfoodology www.realfoodology.com My Immune Supplement by 2x4 Air Dr Air Purifier AquaTru Water Filter EWG Tap Water Database Produced By: Drake Peterson

In this packed solosode of The Red Light Report, Dr. Mike Belkowski returns from the Biohacking Conference in Austin and dives into a rapid-fire review of five compelling new research articles — all centered around mitochondrial health, inflammation, and longevity. Topics covered: • Limonin as a natural anti-inflammatory agent for psoriatic skin via mTORC1 and ROS modulation • The role of mitochondrial oxidative stress in neuroinflammation and age-related diseases • How mitochondrial targeting may offer new treatments for allergic asthma • Photobiomodulation's influence on gut microbiota and its potential to reduce neuroinflammation • The power of C60 fullerenes to enhance muscle recovery, reduce fibrosis, and improve mitochondrial resilience Dr. Mike also shares insight into the new BioBlue Fountain of Youth supplement, highlights the ReVamp red light cupping system, and explains how mitochondrial support may be the next frontier in athletic performance and recovery. Whether you're managing chronic inflammation, recovering from injury, optimizing gut health, or pursuing peak performance, mitochondrial health is the common denominator. This solosode blends research, actionable insights, and clinical tools to help you light up your health from the inside out.   If you found the information in today's episode particularly interesting and/or compelling, please share it with a family member, friend, colleague and/or anyone that you think could benefit and be illuminated by this knowledge. Sharing is caring :)As always, light up your health! - Key points: 00:00 – Introduction: Mitochondrial Health & Podcast Focus 02:13 – Biohacking Conference Recap 03:21 – Return to Nature Retreat Preview 04:43 – Limonin's Anti-Inflammatory Effects 06:06 – Limonin Health Benefits Overview 09:06 – BioBlue Fountain of Youth Supplement 11:48 – Limonin Study Insights 13:48 – Neuroinflammation & Mitochondrial Stress 16:48 – Therapies for Neurodegenerative Diseases 19:01 – Mitochondrial Function in Allergic Asthma 21:27 – Asthma Treatment Strategies 23:52 – Photo Biomodulation & Gut Microbiota 25:53 – How Red Light Restores Gut Balance 28:36 – C60 Fullerenes for Muscle Recovery 31:00 – C60 Reduces Fibrosis in Muscle 33:49 – Red Light Cupping System Benefits 36:37 – Cupping for Athletic Recovery 39:55 – C60 for Athletic Performance 42:26 – Methylene Blue & Athletic Enhancement 44:20 – Episode Wrap-Up & Key Takeaways - Articles referenced in episode: Limonin Exhibits Anti-Inflammatory Effects by Inhibiting mTORC1 and Mitochondrial Reactive Oxygen Species in Psoriatic-like Skin Inflammation   Neuroinflammation in Age-Related Neurodegenerative Diseases: Role of Mitochondrial Oxidative Stress   Targeting mitochondrial function as a potential therapeutic approach for allergic asthma   Photobiomodulation of gut microbiota with low-level laser therapy: a light for treating neuroinflammation   C60 fullerene promotes post-traumatic recovery of the rat muscle gastrocnemius - Unparalleled Mitochondrial Support: BioBlue Fountain of Youth   Save 15% on your order of the Fountain of YouthCode: FOY15ORSave 25% when you purchase the Fountain of Youth via the BioBundle and choose the subscription option!No code necessary -- 25% discount automatically applied!   Shop Fountain of Youth by clicking here. Shop BioBundle by clicking here. - Dr. Mike's #1 recommendations: Water products: Water & Wellness Grounding products: Earthing.com EMF-mitigating products: Somavedic Blue light-blocking glasses: Ra Optics - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

Dr. Kilian Kelly, Chief Executive Officer and Managing Director of Cynata Therapeutics, has taken on the challenge of manufacturing stem cell therapies consistently and at scale in order to drive the advancements necessary for the next generation of regenerative medicine. Cynata is employing a novel approach that utilizes a single source of pluripotent stem cells (iPSCs) and mesenchymal cell ancestors (MCAs) to generate mesenchymal stem cells (MSCs). Lead programs are targeting graft-versus-host disease, osteoarthritis, and diabetic wounds, where clinical trials have shown great promise to treat these and other diseases. Kilian explains, "We're a stem cell regenerative medicine company, and what we're trying to do is to change the way that we can manufacture stem cell therapies in a consistent and scalable way. I'm sure many of your listeners have heard about stem cell therapies of various types. The particular type of cells that we're working on are called mesenchymal stem cells or MSCs. They've shown lots of promise for lots of different purposes, but a real challenge has been making these cells consistently, especially when you try to do that at a large scale. We have a unique novel manufacturing platform, which helps us to address that major challenge." "The way that these cells were historically produced and indeed still are produced in most cases is by harvesting cells from, for example, somebody donating bone marrow or adipose tissue, also known as fat. And those approaches have certainly allowed a lot of early-stage clinical trials to be performed, which showed lots of really exciting results. But often what happens is that when you move to a larger scale using such a process, and you try to make much larger quantities of cells, perhaps using many different donors, you start to see a lot of inconsistency. There are a few reasons for this. When you have inconsistency with a product, it's inevitable that you're going to get inconsistent results." "If you have inconsistent results in a clinical trial, it becomes a bit of a lottery, and sometimes you can have very disappointing results that are hard to explain. So we think that's been a really big issue that has caused a lot of problems in the field. And aside from the impact on clinical trial results, we also need to think about the future when these products are available and on the market, and how you can actually, in practical terms, produce enough of these products. So, in a nutshell, I think that is probably the major challenge that the field has faced."  #CynataTherapeutics #StemCellTherapy #RegenerativeMedicine #iPSCs #MSCs #MCAs Cynata.com Download the transcript here  

Dr. Kilian Kelly, Chief Executive Officer and Managing Director of Cynata Therapeutics, has taken on the challenge of manufacturing stem cell therapies consistently and at scale in order to drive the advancements necessary for the next generation of regenerative medicine. Cynata is employing a novel approach that utilizes a single source of pluripotent stem cells (iPSCs) and mesenchymal cell ancestors (MCAs) to generate mesenchymal stem cells (MSCs). Lead programs are targeting graft-versus-host disease, osteoarthritis, and diabetic wounds, where clinical trials have shown great promise to treat these and other diseases. Kilian explains, "We're a stem cell regenerative medicine company, and what we're trying to do is to change the way that we can manufacture stem cell therapies in a consistent and scalable way. I'm sure many of your listeners have heard about stem cell therapies of various types. The particular type of cells that we're working on are called mesenchymal stem cells or MSCs. They've shown lots of promise for lots of different purposes, but a real challenge has been making these cells consistently, especially when you try to do that at a large scale. We have a unique novel manufacturing platform, which helps us to address that major challenge." "The way that these cells were historically produced and indeed still are produced in most cases is by harvesting cells from, for example, somebody donating bone marrow or adipose tissue, also known as fat. And those approaches have certainly allowed a lot of early-stage clinical trials to be performed, which showed lots of really exciting results. But often what happens is that when you move to a larger scale using such a process, and you try to make much larger quantities of cells, perhaps using many different donors, you start to see a lot of inconsistency. There are a few reasons for this. When you have inconsistency with a product, it's inevitable that you're going to get inconsistent results." "If you have inconsistent results in a clinical trial, it becomes a bit of a lottery, and sometimes you can have very disappointing results that are hard to explain. So we think that's been a really big issue that has caused a lot of problems in the field. And aside from the impact on clinical trial results, we also need to think about the future when these products are available and on the market, and how you can actually, in practical terms, produce enough of these products. So, in a nutshell, I think that is probably the major challenge that the field has faced."  #CynataTherapeutics #StemCellTherapy #RegenerativeMedicine #iPSCs #MSCs #MCAs Cynata.com Listen to the podcast here  

What's New & Exciting in Peri/Menopause Treatment:GLP-1 Medications: Not Just for Weight LossGLP-1s: Micro-dosing for Menopause TherapyGLP-1s side effects you HAVEN'T heard of: The Dopamine EffectHRT: How do you know when it's time to take estrogen or progesterone?Is Weight Gain Inevitable During Menopause?Key Lab Tests for Blood Sugar & Insulin ResistanceHRT: Estrogen, Progesterone, and Testosterone

Send us a textIn this week's Journal Club, Ben and Daphna unpack a wide range of recent neonatal studies with pragmatic, practice-centered discussion. First, they explore a study on low-dose dexamethasone for BPD in preterm infants, showing potential benefits in brain development and motor outcomes—despite ongoing concerns about long-term effects. Next, they discuss a large dataset analysis of oxygen and respiratory support trajectories in extremely preterm infants, offering real-world FiO2 trends and benchmarks that may help frame clinical decisions and counseling.They also examine the diagnostic limits of consumer-grade pulse oximeters, like the Owlet, comparing their accuracy to hospital-grade monitors—raising real concerns about missed events. A safe sleep initiative study offers evidence that modeling and education during birth hospitalization can improve post-discharge sleep practices, especially across different demographic groups. Finally, they review parent engagement with NICU-focused online health communities, identifying both the benefits and potential friction these platforms create in team-family communication.From cerebral oxygenation during kangaroo care to the use of enemas in ELBW infants, this episode covers it all—with a focus on what clinicians can take back to the bedside.Listen in and join the conversation.  As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

I'm diving deep with Regan Archibald, an absolute peptide and regenerative medicine genius to unearth mind-blowing therapies that fight aging, melt fat, heal your body, and sometimes even help you skip surgery entirely. If you're tired, feeling older than your age, or frustrated that traditional protocols aren't moving the needle, you need to hear this. We break down why most people barely scratch the surface when it comes to peptides and why these little protein messengers are the secret to amplifying your results—think faster gut healing, squashing mold toxicity, supercharging immune resilience, and getting you vibrant again on a cellular level. From innovative gut-healing protocols to stacking the right peptides for real transformation, Reagan drops gems that will completely shift your expectations about how fast and radically you can upgrade your health. We also talk muscle preserving, fat-burning, body composition-boosting peptide stacks, and why Rapamycin and Metformin could be sabotaging your muscle building goals as you age. Think next level breakthroughs: exosomes, stem cells and the new world of plasma renewal therapy that's basically an oil change for your blood. Whether you're struggling with pain, aiming for a killer physique, or curious about brain optimization and the future of longevity medicine, this episode is packed with protocols, client stories and takeaways that just might blow your current health plan out of the water. Work with Regan Archibald and his Team https://acueastwest.com/ WHAT DO MY LABS MEAN?! Try the ultimate tool to Decode Your Labs: Understand your thyroid, hormones, and blood sugar numbers to transform your health https://dramie.com/labs/ We prescribe to all 50 states!  When you're ready to FINALLY get the help you deserve… Book a free application call: https://dramie.com/book-a-call/ Shop ALL of Dr. Amie's Fixxr® Supplements: https://betterlifedoctor.com/ EARN CE Credits: "Nurses, hold-on  – here comes the exciting part: you can earn nursing CE credits by listening to our podcasts! That's right—RNegade has teamed up with podcast hosts like me who are delivering amazing content that doesn't limit you to “thinking outside-the box,” it challenges you to BLOW-UP the box by learning from innovators, pioneers, and RENEGADES in the field of health and medicine WHILE EARNING YOUR CEs!” https://rnegade.thinkific.com/?ref=4d98d0 RATE, REVIEW AND FOLLOW ON APPLE PODCASTS If you made it this far I'm impressed! That means you really love the show and I love you for that!  So I'm going to ask you for a favor. Would you please leave a quick review or even 5⭐️. I DO read them and can't tell you how much I appreciate it! Thank you in advance!❤️  Just click here it's quick and easy : https://podcasts.apple.com/us/podcast/the-thyroid-fixer/id1529800263,  Ok ONE MORE favor…would you please subscribe and follow the show? This is a win-win! It tells the podcast powers that be that you like The Thyroid Fixer Podcast AND it lets you catch all the new episodes that come out every week. Follow with this link: https://podcasts.apple.com/us/podcast/the-thyroid-fixer/id1529800263 and never miss out on a moment of the journey! CONNECT WITH ME ON SOCIAL MEDIA: Want to get your labs reviewed and your questions answered LIVE by me? Join my exclusive Facebook group, Just Fix Your Thyroid – a supportive and empowering community designed to give you the tools, guidance, and HOPE you need on your thyroid and hormone journey.

Send us a textJohn Ferrera Ph.D is a returning guest on our show! Be sure to check out his recent appearance on episode 551 of Boundless Body Radio!John Ferrera Ph.D. is a Neuropsychologist who specializes in psychological and neuropsychological assessment. He has a Ph.D. from the Clinical Neuropsychology program of the CUNY Graduate Center and has been a Licensed Psychologist since 2010.As a young Neuropsychologist in his early 30's, he learned that he had a sensitivity to gluten and was experiencing flare-ups of psoriasis. Currently, Dr. Ferrera is the owner and operator of Integrative Neuropsychological Services PLLC, founded in 2012. His specialties include but are not limited to Autism, dyslexia or reading disability, nonverbal learning disability, and other complex presentations.In addition to his work as a Neuropsychologist, he specializes in integrative and functional medicine and offers integrative or metabolic health coaching for individuals and families. Dr. Ferrera is also a certified Chris Kresser Functional Medicine Practitioner, and has also completed an ADHD fellowship through the Psychiatry Redefined platform of James Greenblatt, MD.Find Dr. John  Fererra at-https://www.inpnyc.com/TW- @JohnFerreraPHDDocumentary on Autism- https://www.restoringbalanceautism.com/the-movieFind Boundless Body at- myboundlessbody.com Book a session with us here!

Send us a textIn this episode of At The Bench, Drs. Misty Good and Betsy Crouch speak with Dr. Stephanie Gaw, a maternal-fetal medicine specialist at UCSF, about her path to becoming a physician-scientist and her translational research on placental infections. Dr. Gaw shares how early lab experiences, time in the Peace Corps, and a pivot from infectious disease to OB-GYN shaped her focus on maternal immunity and global health.The conversation covers Dr. Gaw's work on sepsis in pregnancy, COVID-19 and RSV vaccine responses, and congenital infections like syphilis. She also discusses her approach to building and managing a large placental biorepository, and the importance of thoughtful sample collection for reliable research outcomes. The episode includes practical insights on balancing clinical duties with research, the benefits of peer mentorship, and how clinical observations can drive lab-based investigation.This discussion offers a clear look into the realities and rewards of bridging bedside observations with bench research in maternal-fetal medicine. It's a valuable listen for early-career physician-scientists and anyone interested in the complexities of immunology, placental biology, and perinatal infection.As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

This episode is brought to you by State & Liberty, Blokes & Joi, Fatty15 and FLYKITT. Bbiochemist and biomolecular therapy expert Jay Spall joins us to unravel his transformative journey from spinal injury to becoming a leading figure in the world of biohacking and longevity. Jay shares groundbreaking insights into follistatin therapy, detailing its impressive effects on endurance, body composition, and overall well-being. His personal narrative, combined with scientific research and anecdotes, paints a vivid picture of how cutting-edge therapies can enhance human performance and extend the quality of life. Follow MiniCircle @minicircledna Follow Chase @chase_chewning ----- In this episode we discuss... (00:01) Introduction to Biochemical Therapy (10:07) Reclaiming Our Health Through (17:30) Hormone Optimization Therapies (32:09) Modern Progressive Interventions (42:28) Taking Healthcare Power Back by Our Choices (54:49) Neurological Therapy (01:07:45) Gene Therapy for Health and Longevity (01:14:55) How to Actually Measure Longevity (01:22:14) Maximizing Healthspan and Lifespan With Gene Therapy (01:31:09) Why Community Matters (01:36:05) Connecting With MiniCircle ----- Episode resources: Save 15% on the best-fitting men's clothes with code CHASE at https://www.StateAndLiberty.com  Save 10% on any diagnostic labs with code CHASE at https://www.JoiAndBlokes.com  Save an additional 15% on the 90-day starter kit of C15:0 essential fatty acid with code EVERFORWARD at https://www.Fatty15.com/everforward  Never get jet lag again and save 15% with code CHASE at https://www.FLYKITT.com  Watch and subscribe on YouTube Learn more at MiniCircle.io